Grahic Jump Location
Epipedobates tricolor, the Ecuadoran frog
from whose skin scientists have isolated the alkoloid epibatidine, leading
to a new synthetic analgesic. (Photo credit: John W. Daly, PhD)
Conus purpurascens, the purple cone, one
of hundreds of species of venomous cone snails found in tropical waters, extends
its proboscis as it prepares to sting its prey. Synthetic copies of the snails'
complex venom are being studied as analgesics. (Photo credit: Baldomero M.
Olivera, PhD, and Nature)
Echis carinatus, the saw-scaled viper, found
in Africa, poisons with venom containing a clot-preventing protein. A similar
synthesized protein may be used to treat cardiac ischemic syndrome. (Photo
credit: Merck & Co, Inc)
Grahic Jump Location
Epipedobates tricolor, the Ecuadoran frog
from whose skin scientists have isolated the alkoloid epibatidine, leading
to a new synthetic analgesic. (Photo credit: John W. Daly, PhD)
Conus purpurascens, the purple cone, one
of hundreds of species of venomous cone snails found in tropical waters, extends
its proboscis as it prepares to sting its prey. Synthetic copies of the snails'
complex venom are being studied as analgesics. (Photo credit: Baldomero M.
Olivera, PhD, and Nature)
Echis carinatus, the saw-scaled viper, found
in Africa, poisons with venom containing a clot-preventing protein. A similar
synthesized protein may be used to treat cardiac ischemic syndrome. (Photo
credit: Merck & Co, Inc)
Grahic Jump Location
Epipedobates tricolor, the Ecuadoran frog
from whose skin scientists have isolated the alkoloid epibatidine, leading
to a new synthetic analgesic. (Photo credit: John W. Daly, PhD)
Conus purpurascens, the purple cone, one
of hundreds of species of venomous cone snails found in tropical waters, extends
its proboscis as it prepares to sting its prey. Synthetic copies of the snails'
complex venom are being studied as analgesics. (Photo credit: Baldomero M.
Olivera, PhD, and Nature)
Echis carinatus, the saw-scaled viper, found
in Africa, poisons with venom containing a clot-preventing protein. A similar
synthesized protein may be used to treat cardiac ischemic syndrome. (Photo
credit: Merck & Co, Inc)